X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
STERLING BIOTECH LIMITED Fact Sheet - Equitymaster
Investing in India? Get Equitymaster Research  

STERLING BIOTECH LIMITED  (STEA)


Here is the latest financial fact sheet of Sterling Biotech. For more details, see the Sterling Biotech quarterly results and Sterling Biotech share price and chart.
 
sterling biotech - 1 Year Stock Price Chart
Loading...

 Price History
    Price Rs 5.5       No. of shares m 272.05
    Mkt Cap Rs m 1,488       % ch % -0.7
    Vol '000 65.1       % ch week % 1.7
    P/E X -2.6       % ch 1-mth % 37.8
    P/CF X -1.0       % ch 12-mth % 33.1
    EPS (TTM) Rs -2.1       52 week H/L Rs 6.8/3.0
(As on Apr 27, 2017 (Close)) »  Best Performing pharmaceuticals Stocks

Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!
 Financials

* Results Consolidated
No. of Months
Year Ending
12
Dec-09
12
Dec-10
12
Dec-11
12
Dec-12
12
Dec-13
5-Yr Chart
Click to enlarge
  EQUITY SHARE DATA
High Rs1701261072011 
Low Rs90902153 
Sales per share (Unadj.) Rs57.560.362.031.226.8 
Earnings per share (Unadj.) Rs9.55.50.7-13.1-15.0 
Diluted earnings per shareRs8.75.40.7-12.9-14.7 
Cash flow per share (Unadj.) Rs14.412.810.2-3.4-5.5 
Dividends per share (Unadj.) Rs0.500.50000 
Adj. dividends per shareRs0.460.490.000.000.00 
Dividend yield (eoy) %0.40.5000 
Book value per share (Unadj.) Rs82.292.093.069.854.9 
Adj. book value per shareRs75.690.691.668.854.0 
Shares outstanding (eoy) m250.20267.87267.87267.87267.87 
Bonus/Rights/Conversions  BCBC--- 
Price / Sales ratio x2.31.81.00.40.3 
Avg P/E ratio x13.719.886.0-1.0-0.5 
P/CF ratio (eoy) x9.08.46.3-3.7-1.3 
Price / Book Value ratio x1.61.20.70.20.1 
Dividend payout %5.39.2000 
Avg Mkt Cap Rs m32,52628,93017,1573,3751,862 
No. of employees `000NANANA1.41.4 
Total wages/salary Rs m402437506537547 
Avg. sales/employee Rs ThNMNMNM6,049.15,303.3 
Avg. wages/employee Rs ThNMNMNM389.0403.8 
Avg. net profit/employee Rs ThNMNMNM-2,534.6-2,959.0 
  INCOME DATA
Net Sales Rs m14,38216,16616,6208,3487,181 
Other income Rs m89106937043 
Total revenues Rs m14,47016,27216,7138,4187,223 
Gross profit Rs m5,0556,9716,3741,476947 
Depreciation Rs m1,2301,9762,5222,5882,543 
Interest Rs m1,4942,3052,7044,1234,377 
Profit before tax Rs m2,4192,7961,241-5,165-5,931 
Minority Interest Rs m00000 
Prior Period Items Rs m179800 
Extraordinary Inc (Exp) Rs m621-631-962-120 
Tax Rs m68671287-1,680-1,924 
Profit after tax Rs m2,3701,462200-3,498-4,007 
Gross profit margin %35.243.138.417.713.2 
Effective tax rate %28.425.57.032.532.4 
Net profit margin %16.59.01.2-41.9-55.8 
  BALANCE SHEET DATA
Current assets Rs m18,51021,69821,81915,22214,335 
Current liabilities Rs m13,28812,55828,22339,28749,809 
Net working cap to sales %36.356.5-38.5-288.3-494.0 
Current ratio x1.41.70.80.40.3 
Inventory Days Days143155222380403 
Debtors Days Days150153159152171 
Net fixed assets Rs m34,00541,07745,87651,84955,432 
Share capital Rs m250268268268268 
"Free" reserves Rs m20,23924,12024,25017,94213,935 
Net worth Rs m20,56424,64924,90918,70814,701 
Long term debt Rs m18,60126,09015,06511,3749,478 
Total assets Rs m55,26266,41471,34570,83773,988 
Interest coverage x2.62.21.5-0.3-0.4 
Debt to equity ratio x0.91.10.60.60.6 
Sales to assets ratio x0.30.20.20.10.1 
Return on assets %7.05.74.10.90.5 
Return on equity %11.55.90.8-18.7-27.3 
Return on capital %11.68.87.5-3.5-6.4 
Exports to sales %31.631.130.926.725.9 
Imports to sales %0.40.30.50.10.2 
Exports (fob) Rs m4,5385,0355,1412,2301,860 
Imports (cif) Rs m545582412 
Fx inflow Rs m4,5385,0355,1412,2301,860 
Fx outflow Rs m708417710825 
Net fx Rs m4,4684,9514,9642,1221,835 
  CASH FLOW
From Operations Rs m -13 3,482 3,697 8,113 1,719 
From Investments Rs m -4,213 -9,940 -7,332 -8,116 -3,148 
From Financial Activity Rs m 4,495 6,749 2,271 -38 1,426 
Net Cashflow Rs m 269 291 -1,364 -42 -3 
* Results Consolidated Source: Company Annual Reports, Regulatory Filings, Equitymaster »  Historical quarterly results for sterling biotech limited

 Share Holding
Indian Promoters : 33.9%
Foreign collaborators : 0.0%
Indian inst/Mut Fund : 0.0%
FIIs : 9.9%
ADR/GDR : 16.9%
Free float : 39.3%
Shareholders : 21,482
Pledged promoter(s) holding : 55.9%
 Company Information
Top
    REGD OFF: 43, Atlanta Building, Nariman Point, Mumbai - 400 021
    E-MAIL: investorscomplain@stergel.com     WEB: www.sterlingbiopharma.com
    TELEPHONE: (022) 6630 6732     FAX: (022) 2204 1954
    SECTOR: PHARMACEUTICALS     GROUP: MISCELLANEOUS
    TR AGENT: Link Intime India, C13, Pannalal Silk Mills Compd., LBS Marg, Mumbai-78
    AUDITOR: H. S. Hathi & Co.
CHM: Nitin J. Sandesara (MD) COMP SEC: Megha Chokshi YEAR OF INC: 1900 BSE CODE: 512299 FV (Rs): 1 DIV YIELD (%): -

More pharmaceuticals Company Fact Sheets:   GODFREY PHILLIPSAGRO TECH FOODSUNITED SPIRITSHERITAGE FOODZYDUS WELLNESS


Today's Market

Sensex Finishes Lower; Metal & FMCG Stocks Drag(Closing)

Share markets in India finished on a weak note as investors continued to book profits ahead of the April F&O expiry. At the closing bell, the BSE Sensex closed lower by 104 points.

Views on news

ITC: Demonetisation woes pull down business growth (Quarterly Results Update - Detailed)

Feb 8, 2017

ITC Ltd has announced third quarter results of the financial year 2016-2017 (3QFY17). The company has reported 4.7% YoY and 5.7% YoY growth in revenues and net profits respectively. Here is our analysis of the results.

ITC: A Decent Quarter Amidst Challenging Environment (Quarterly Results Update - Detailed)

Dec 7, 2016

ITC has announced second quarter results of the financial year 2016-2017 (2QFY17). The company has reported 8% YoY and 10.5% YoY growth in revenues and net profits respectively.

A Little Gem in the FMCG Sector (Sector Info)

Jul 18, 2016

Will investing in Bajaj Corp yield high returns on account of a rural revival in sight?

Parag Milk Foods Limited (IPO)

May 4, 2016

Should you subscribe to Parag Milk Foods' initial public offering?

Manpasand Beverages Limited IPO - Our view (IPO)

Jun 23, 2015

Equitymaster analyses the Initial Public Offering (IPO) of Manpasand Beverages Limited.

More Views on News

Most Popular

Our Private Class with India's Value Investing Guru(The 5 Minute Wrapup)

Apr 19, 2017

Rohan and Kunal present you the discussions with professor Sanjay Bakshi in his virtual classroom.

HDFC Bank: The Solid Outperformer(Chart Of The Day)

Apr 22, 2017

Why HDFC Bank beat the Sensex by nearly 3 times.

The Real Reason Indiabulls Real Estate Jumped 42%(Daily Profit Hunter)

Apr 19, 2017

An elephant and six blind men will tell you more about the markets than any financial newspaper or channel.

In an Ocean of Corporate Defaulters, Vijay Mallya is a Small Fish(Vivek Kaul's Diary)

Apr 20, 2017

While it is important to get Mallya back to India, the government needs to show the same vigour in chasing defaulters of public sector bank loans residing in India.

4 Ways GST Will Impact The Mutual Fund Industry(Outside View)

Apr 19, 2017

PersonalFN explains how GST would impact India's mutual fund industry and investors

More

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH - SANOFI INDIA COMPARISON

Compare Company With Charts

COMPARE STERLING BIOTECH WITH

MARKET STATS